Margot Rosenthal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Margot Rosenthal has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Sarah K. McQuillan
Département d’obstétrique, de gynécologie et des sciences de la reproduction (Rosenthal), Université du Manitoba, Winnipeg, Man.; Département d’obstétrique et de gynécologie (McQuillan), Université de Calgary, Calgary, Alb
2 shared publications- Vanessa Poliquin
Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Manitoba, Winnipeg, MB
2 shared publications Adelicia Yu
Department of Obstetrics, Gynecology and Reproductive Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada
1 shared publication- Alyssa R. Golden
Public Health Agency of Canada
1 shared publication Ben Fultz
Department of Medical Microbiology, College of Medicine, Faculty of Health Sciences, University of Manitoba, 727 McDermot Avenue, Winnipeg, Manitoba R3E 3P5, Canada
1 shared publicationDaryl J. Hoban
Department of Medical Microbiology, College of Medicine, Faculty of Health Sciences, University of Manitoba, 727 McDermot Avenue, Winnipeg, Manitoba R3E 3P5, Canada Clinical Microbiology - Health Sciences Centre, Diagnostic Services Manitoba, MS673-820 Sherbrook Street, Winnipeg, Manitoba R3A 1R9, Canada
1 shared publication
Latest Publications
- 24 February 2022
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Canada Communicable Disease Report
- Vol. 48 (2-3) , 111-114
Exploring management of antenatally diagnosed fetal syphilis infection
Background: The incidence of syphilis among Canadian women of childbearing age has risen dramatically in the past decade, with a resurgence of infants born with congenital syphilis. While guidelines exist to guide maternal infection during pregnancy, there is little evidence available to guide management in situations where the developing fetus is found to be severely affected. Case review: Our patient presented in the second trimester of her pregnancy as syphilis contact. Positive serologic tests (venereal disease research laboratory titre of 1:64) and a chancre suggested primary infection. Ultrasound demonstrated a fetus at 19+3 weeks gestation with hydrops fetalis and a markedly abnormal brain. Amniocentesis confirmed congenital syphilis infection on polymerase chain reaction testing. After nine days of intravenous penicillin G, the fetal status had worsened, and the family ultimately chose a medical termination of the pregnancy. Discussion: Evolving ultrasound technology has allowed us to identify severely affected fetuses, who may historically have been delivered stillborn. Following routine syphiliotherapy with benzathine penicillin, these abnormal ultrasound features may take weeks or months to reverse, which poses a challenge in prognostication and counselling. Case reports data suggests intensive treatment with intravenous penicillin may be effective in severe cases where fetal hydrops is present. Conclusion: This case highlights the potential morbidity of fetal syphilis infection and underscores the paucity of current literature. Information sharing will be essential to build a modern knowledge base on treating this ancient disease.
- 24 February 2022
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Canada Communicable Disease Report
- Vol. 48 (2-3) , 111-114
Exploring management of antenatally diagnosed fetal syphilis infection
Background: The incidence of syphilis among Canadian women of childbearing age has risen dramatically in the past decade, with a resurgence of infants born with congenital syphilis. While guidelines exist to guide maternal infection during pregnancy, there is little evidence available to guide management in situations where the developing fetus is found to be severely affected. Case review: Our patient presented in the second trimester of her pregnancy as syphilis contact. Positive serologic tests (venereal disease research laboratory titre of 1:64) and a chancre suggested primary infection. Ultrasound demonstrated a fetus at 19+3 weeks gestation with hydrops fetalis and a markedly abnormal brain. Amniocentesis confirmed congenital syphilis infection on polymerase chain reaction testing. After nine days of intravenous penicillin G, the fetal status had worsened, and the family ultimately chose a medical termination of the pregnancy. Discussion: Evolving ultrasound technology has allowed us to identify severely affected fetuses, who may historically have been delivered stillborn. Following routine syphiliotherapy with benzathine penicillin, these abnormal ultrasound features may take weeks or months to reverse, which poses a challenge in prognostication and counselling. Case reports data suggests intensive treatment with intravenous penicillin may be effective in severe cases where fetal hydrops is present. Conclusion: This case highlights the potential morbidity of fetal syphilis infection and underscores the paucity of current literature. Information sharing will be essential to build a modern knowledge base on treating this ancient disease.
- Open Access
- 24 February 2022
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Relevé des maladies transmissibles au Canada
- Vol. 48 (2-3) , 125-129
Examen de la gestion de l’infection à la syphilis congénitale diagnostiquée avant la naissance
- 24 February 2022
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Relevé des maladies transmissibles au Canada
- Vol. 48 (2-3) , 125-129
Open AccessExamen de la gestion de l’infection à la syphilis congénitale diagnostiquée avant la naissance
- Open Access
- 19 September 2021
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 193 (37) , E1475-E1476
Contraception chez les adolescentes
Au Canada, les naissances vivantes chez les mères de moins de 19 ans représentaient 5,3 % des cas en 2000, 4 % des cas en 2010 et 1,7 % des cas en 20191. Cependant, plus de 80 % des grossesses de mères adolescentes sont non planifiées et plusieurs sont interrompues2. La Société canadienne de pédiatrie recommande un accès rapide aux méthodes de contraception et des ordonnances à renouvellement annuel afin de diminuer l’incidence des grossesses non planifiées et d’augmenter le taux de poursuite de la contraception3.
- 19 September 2021
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 193 (37) , E1475-E1476
Open AccessContraception chez les adolescentes
Au Canada, les naissances vivantes chez les mères de moins de 19 ans représentaient 5,3 % des cas en 2000, 4 % des cas en 2010 et 1,7 % des cas en 20191. Cependant, plus de 80 % des grossesses de mères adolescentes sont non planifiées et plusieurs sont interrompues2. La Société canadienne de pédiatrie recommande un accès rapide aux méthodes de contraception et des ordonnances à renouvellement annuel afin de diminuer l’incidence des grossesses non planifiées et d’augmenter le taux de poursuite de la contraception3.
- Open Access
- 8 August 2021
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 193 (31) , E1218
Adolescent contraception
In Canada, 5.3% of live births in 2000, 4% in 2010 and 1.7% in 2019, were to mothers younger than 19 years old.1 More than 80% of adolescent pregnancies, however, are unplanned and many end in termination.2 The Canadian Pediatric Society recommends quick-start methods of contraception and year-long prescriptions to decrease unplanned pregnancies and increase continuation rates.3
- 8 August 2021
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 193 (31) , E1218
Open AccessAdolescent contraception
In Canada, 5.3% of live births in 2000, 4% in 2010 and 1.7% in 2019, were to mothers younger than 19 years old.1 More than 80% of adolescent pregnancies, however, are unplanned and many end in termination.2 The Canadian Pediatric Society recommends quick-start methods of contraception and year-long prescriptions to decrease unplanned pregnancies and increase continuation rates.3
- 1 August 2021
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 28 (8) , 1440-1441
An Unusual Finding of 2 Cesarean Scar Defects in a Patient with History of Multiple Cesarean Sections
- 1 August 2021
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 28 (8) , 1440-1441
An Unusual Finding of 2 Cesarean Scar Defects in a Patient with History of Multiple Cesarean Sections
- 27 May 2021
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 26 (7) , 394-395
What do I need to know about the etonogestrel-relesasing contraceptive implant (Nexplanon)?
The Canadian Paediatric Society endorses long-acting reversible contraception (LARC) methods as first line in the adolescent population ( 1). Previously, the only options on the Canadian market were intrauterine devices (IUDs), either copper or hormonal. The Nexplanon contraceptive implant is a new option for our patients, which is now available following Health Canada approval in 2020.
- 27 May 2021
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 26 (7) , 394-395
What do I need to know about the etonogestrel-relesasing contraceptive implant (Nexplanon)?
The Canadian Paediatric Society endorses long-acting reversible contraception (LARC) methods as first line in the adolescent population ( 1). Previously, the only options on the Canadian market were intrauterine devices (IUDs), either copper or hormonal. The Nexplanon contraceptive implant is a new option for our patients, which is now available following Health Canada approval in 2020.
- Open Access
- 1 January 2020
- Published by Taylor & Francis in International Journal of Circumpolar Health
- Vol. 79 (1) , 1710894
Maternal hypothermia from environmental exposure in the third trimester
A primigravida at 32 weeks gestation developed hypothermia after prolonged exposure to the elements at -30.0°C. Her core temperature dropped to 29.8°C with associated foetal bradycardia. Passive rewarming was undertaken with forced warm air blankets and warmed IV fluids. The foetal heart rate normalised once normothermia was achieved. Serial foetal assessments showed appropriate growth and normal Doppler studies. She went to on deliver a healthy term infant. This case highlights conservative management and prioritising of maternal well-being with a good maternal and foetal outcome.
- 1 January 2020
- Published by Taylor & Francis in International Journal of Circumpolar Health
- Vol. 79 (1) , 1710894
Open AccessMaternal hypothermia from environmental exposure in the third trimester
A primigravida at 32 weeks gestation developed hypothermia after prolonged exposure to the elements at -30.0°C. Her core temperature dropped to 29.8°C with associated foetal bradycardia. Passive rewarming was undertaken with forced warm air blankets and warmed IV fluids. The foetal heart rate normalised once normothermia was achieved. Serial foetal assessments showed appropriate growth and normal Doppler studies. She went to on deliver a healthy term infant. This case highlights conservative management and prioritising of maternal well-being with a good maternal and foetal outcome.
- 28 April 2015
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 70 (8) , 2199-2202
Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007–13
The goal of this study was to characterize Streptococcus pneumoniae demonstrating MDR (resistant to three or more antimicrobial classes) or XDR (resistant to five or more classes) phenotypes, collected from Canada during the CANWARD 2007–13 study. From 2007 to 2013 inclusive, S. pneumoniae isolates were collected as a part of the CANWARD surveillance study. MDR and XDR isolates were subjected to PFGE, MLST, molecular detection of pneumococcal pili and macrolide resistance determinants mef(A/E) and erm(B), sequencing of PBPs 1A, 2B and 2X and comparison with Pneumococcal Molecular Epidemiology Network (PMEN) clones. Of 2129 S. pneumoniae isolates collected during the CANWARD 2007–13 study, 61 (2.9%) were found to be MDR. Of these MDR isolates, 43 (70.5%) were XDR. The most common serotypes for both MDR and XDR S. pneumoniae were 19A and 19F. Twenty-nine of 61 isolates (48%) demonstrated resistance to clarithromycin, clindamycin, doxycycline, penicillin and trimethoprim/sulfamethoxazole. All isolates possessed at least one macrolide resistance determinant and mutations in PBPs 1A, 2B and 2X. The most common clone was piliated, XDR ST320, an internationally circulating double-locus variant of Taiwan19F-14 (ST236). Though the rate of MDR S. pneumoniae has remained relatively stable since 2007, XDR strains have emerged in Canada. These strains are virulent, possess resistance determinants and are related to international clones.
- 28 April 2015
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 70 (8) , 2199-2202
Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007–13
The goal of this study was to characterize Streptococcus pneumoniae demonstrating MDR (resistant to three or more antimicrobial classes) or XDR (resistant to five or more classes) phenotypes, collected from Canada during the CANWARD 2007–13 study. From 2007 to 2013 inclusive, S. pneumoniae isolates were collected as a part of the CANWARD surveillance study. MDR and XDR isolates were subjected to PFGE, MLST, molecular detection of pneumococcal pili and macrolide resistance determinants mef(A/E) and erm(B), sequencing of PBPs 1A, 2B and 2X and comparison with Pneumococcal Molecular Epidemiology Network (PMEN) clones. Of 2129 S. pneumoniae isolates collected during the CANWARD 2007–13 study, 61 (2.9%) were found to be MDR. Of these MDR isolates, 43 (70.5%) were XDR. The most common serotypes for both MDR and XDR S. pneumoniae were 19A and 19F. Twenty-nine of 61 isolates (48%) demonstrated resistance to clarithromycin, clindamycin, doxycycline, penicillin and trimethoprim/sulfamethoxazole. All isolates possessed at least one macrolide resistance determinant and mutations in PBPs 1A, 2B and 2X. The most common clone was piliated, XDR ST320, an internationally circulating double-locus variant of Taiwan19F-14 (ST236). Though the rate of MDR S. pneumoniae has remained relatively stable since 2007, XDR strains have emerged in Canada. These strains are virulent, possess resistance determinants and are related to international clones.